Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 9/20 | 0.56 |
| ▸ | MAPT | P10636 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | RECQL | P46063 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12713391 | 0.84 | LMNA (0.64) | LMNAMAPTALDH1A1SMN1; SMN2HTT | |
| SCHEMBL12713425 | 0.84 | LMNA (0.78) | LMNAMAPTALDH1A1SMN1; SMN2HTT | |
| SCHEMBL12713397 | 0.83 | LMNA (0.63) | LMNAMAPTALDH1A1SMN1; SMN2HTT | |
| SCHEMBL12713395 | 0.82 | LMNA (0.69) | LMNAMAPTALDH1A1SMN1; SMN2HTT | |
| SCHEMBL12713460 | 0.81 | LMNA (0.53) | LMNAMAPTALDH1A1SMN1; SMN2CYP2C19 | |
| SCHEMBL12713401 | 0.79 | LMNA (0.57) | LMNAMAPTALDH1A1SMN1; SMN2HTT | |
| SCHEMBL12713398 | 0.79 | LMNA (0.59) | LMNAMAPTALDH1A1SMN1; SMN2HTT | |
| SCHEMBL12713388 | 0.78 | LMNA (0.63) | LMNAMAPTALDH1A1SMN1; SMN2HTT | |
| SCHEMBL12713389 | 0.76 | LMNA (0.55) | LMNAMAPTALDH1A1SMN1; SMN2HTT | |
| SCHEMBL18883830 | 0.73 | LMNA (0.50) | LMNAMAPTALDH1A1SMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9657031-B2 | Ant-ligands molecules and biological applications | UNIVERSITE DE VERSAILLES-SAINT-QUENTIN-EN-YVELINES (FR) | 2017-05-23 | — | — | US | disclosed |
| US-9657031-B2 | Ant-ligands molecules and biological applications | UNIVERSITE DE VERSAILLES-SAINT-QUENTIN-EN-YVELINES (FR) | 2017-05-23 | — | — | US | disclosed |
| US-20140350033-A1 | ANT-LIGANDS MOLECULES AND BIOLOGICAL APPLICATIONS | MITOLOGICS (FR) | 2014-11-27 | — | — | US | disclosed |
| US-20140350033-A1 | ANT-LIGANDS MOLECULES AND BIOLOGICAL APPLICATIONS | MITOLOGICS (FR) | 2014-11-27 | — | — | US | disclosed |
| US-8809346-B2 | ANT-ligands molecules and biological applications | UNIVERSITE DE VERSAILLES-SAINT-QUENTIN-EN-YVELINES (FR) | 2014-08-19 | — | — | US | disclosed |
| US-8809346-B2 | ANT-ligands molecules and biological applications | UNIVERSITE DE VERSAILLES-SAINT-QUENTIN-EN-YVELINES (FR) | 2014-08-19 | — | — | US | disclosed |
| US-20110086865-A1 | ANT-LIGANDS MOLECULES AND BIOLOGICAL APPLICATIONS | MITOLOGICS (FR) | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140350033-A1 | ANT-LIGANDS MOLECULES AND BIOLOGICAL APPLICATIONS | CXCR3, ACKR3, CCR3 | LMNA 2370/4885MAPT 4797/4885ALDH1A1 2899/4885 |
| US-20110086865-A1 | ANT-LIGANDS MOLECULES AND BIOLOGICAL APPLICATIONS | CXCR3, ACKR3, CCR3 | LMNA 2515/4885MAPT 4805/4885ALDH1A1 2352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.